参考文献

［1] JANUARY C T，WANN L S，CALKINS H，et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation［J］. Circulation，2019，140（2）：e125-e151.

［2] HINDRICKS G，POTPARA T，DAGRES N，et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery（EACTS）［J］. Eur Heart J，2020：ehaa612.

［3] CALKINS H，HINDRICKS G，CAPPATO R，et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation［J］. Europace，2018，20（1）：e1-e160.

［4] KARASOY D，GISLASON G H，HANSEN J，et al. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding：Long-term follow-up in nationwide cohort of Denmark［J］.Eur Heart J，2015，36（5）：307-14a.

［5] FRIBERG L，TABRIZI F，ENGLUND A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death：data from Swedish health registries［J］. Eur Heart J，2016，37（31）：2478-2487.

［6] SALIBA W，SCHLIAMSER J E，LAVI I，et al. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality：A propensity score-matched analysis［J］. Heart Rhythm，2017，14（5）：635-642.

［7] CHANG C H，LIN J W，CHIU F C，et al. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality：a nationwide cohort study and propensity score analysis［J］. Circ Arrhythm Electrophysiol，2014，7（1）：76-82.

［8] MANSOUR M，HEIST E K，AGARWAL R，et al. Stroke and cardiovascular events after ablation or antiarrhythmic drugs for treatment of patients with atrial fibrillation［J］. Am J Cardiol，2018，121（10）：1192-1199.

［9] SRIVATSA U N，DANIELSEN B，AMSTERDAM E A，et al. CAABL-AF（California Study of Ablation for Atrial Fibrillation）：Mortality and stroke，2005 to 2013［J］. Circ Arrhythm Electrophysiol，2018，11（6）：e005739.

［10] HUNTER R J，MCCREADY J，DIAB I，et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death［J］. Heart，2012，98（1）：48-53.

［11] BUNCH T J，CRANDALL B G，WEISS J P，et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death，stroke，and dementia similar to patients without atrial fibrillation［J］. J Cardiovasc Electrophysiol，2011，22（8）：839-845.

［12] BUNCH T J，MAY H T， BAIR T L，et al. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke［J］. J Cardiovasc Electrophysiol，2018，29（2）：221-226.

［13] JARMAN J W，HUNTER T D，HUSSAIN W，et al. Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK［J］. Pragmat Obs Res，2017，8：107-118.

［14] NADEMANEE K， AMNUEYPOL M，LEE F，et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation［J］. Heart Rhythm，2015，12（1）：44-51.

［15] ZHOU G，CAI L，WU X，et al. Clinical efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in patients aged ≥ 80 years［J］. Pacing Clin Electrophysiol，2020.

［16] KIM D H，LEE D L，AHN J，et al. Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea［J］. PLoS One，2018，13（7）：e0201061.

［17] SANTARPIA G，ROSA S D，SABATINO J，et al. Should we maintain anticoagulation after successful radiofrequency catheter ablation of atrial fibrillation ？ The need for a randomized study［J］. Front Cardiovasc Med，2017，4：85.

［18] PROIETTI R，ALTURKI A，BIASE L D，et al. Anticoagulation after catheter ablation of atrial fibrillation：An unnecessary evil？ A systematic review and meta-analysis［J］. J Cardiovasc Electrophysiol，2019，30（4）：468-478.

［19] DENG L，XIAO Y，HONG H. Withdrawal of oral anticoagulants 3 months after successful radiofrequency catheter ablation in patients with atrial fibrillation：A meta-analysis［J］. Pacing Clin Electrophysiol，2018，41（11）：1391-1400.

［20] ROMERO J，AVENDANO R，DIAZ J C，et al. Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation ？［J］. Expert Rev Cardiovasc Ther，2019，17（1）：31-41.

［21] TOSO E，PEYRACCHIA M， MATTA M，et al. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation：A systematic review and meta-analysis［J］.Int J Cardiol，2018，270：172-179.

［22] PACKER D L，MARK D B，ROBB R A，et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality，stroke，bleeding，and cardiac arrest among patients with atrial fibrillation：The CABANA randomized clinical trial［J］. JAMA，2019，321（13）：1261-1274.

［23] VERMA A，HA A C，KIRCHHOF P，et al. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation（OCEAN）trial［J］. Am Heart J，2018，197：124-132.

［24] KHAN M N，JAÏS P，CUMMINGS J，et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure［J］. N Engl J Med，2008，359（17）：1778-1785.

［25] PRABHU S，TAYLOR A J，COSTELLO B T，et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction：The CAMERA-MRI study［J］. J Am Coll Cardiol，2017，70（16）：1949-1961.

［26] MARROUCHE N F，BRACHMANN J，ANDRESEN D，et al. Catheter ablation for atrial fibrillation with heart failure［J］. N Engl J Med，2018，378（5）：417-427.

［27] BIASE L D，MOHANTY P，MOHANTY S，et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device：Results from the AATAC multicenter randomized trial［J］.Circulation，2016，133（17）：1637-1644.

［28] CHEN S，PÜRERFELLNER H，MEYER C，et al. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation：a stratified pooled analysis of randomized data［J］. Eur Heart J，2020，41（30）：2863-2873.

［29] STABILE G，LEPILLIER A，DE RUVO E，et al. Reproducibility of pulmonary vein isolation guided by the ablation index：1-year outcome of the AIR registry［J］. J Cardiovasc Electrophysiol，2020，31（7）：1694-1701.

［30] CLARK D M，PLUMB V J，EPSTEIN A E，et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation［J］. J Am Coll Cardiol，1997，30（4）：1039-1045.

［31] DEEDWANIA P C，LARDIZABAL J A. Atrial fibrillation in heart failure：a comprehensive review［J］. Am J Med，2010，123（3）：198-204.

［32] CHEN L Y，CHUNG M K，ALLEN L A，et al. Atrial fibrillation burden：Moving beyond atrial fibrillation as a binary entity：A scientific statement from the American Heart Association［J］. Circulation，2018，137（20）：e623-e644.

［33] KIRCHHOF P，CAMM A J，GOETTE A，et al. Early rhythm-control therapy in patients with atrial fibrillation［J］. N Engl J Med，2020.